4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-24-000141
Chief Accounting Officer sold 1,357 shares at $14.97 ($20,314)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Azoy Alexander Chief Accounting Officer | 2024-08-13 | Sale 10b5-1 | −1,357 | $14.97 | $20,314 | 19,070 | D: show line 1 in the form |
| Open-market sales · 1,357 sh · avg $14.97 · $20,314 | |||||||
Loading xslF345X05/wk-form4_1723754700.xml…